Your session is about to expire
← Back to Search
Reduced-Dose IMRT for Soft Tissue Sarcoma
Study Summary
This trial is testing if a lower dose of radiation can still be effective in treating soft tissue sarcomas and if it has fewer side effects than the standard dose.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 38 Patients • NCT04529850Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not receiving treatment for another type of invasive cancer.My sarcoma diagnosis in my arm or leg has been confirmed by a specialist.I am a woman who can have children and have a recent negative pregnancy test.My surgery for cancer left some cancer cells, as confirmed by a pathology review.I am 18 years old or older.My cancer surgery removed all visible cancer, confirmed by a pathology review.I can start radiation therapy within 3 months after my surgery.I have been diagnosed with a specific type of soft tissue cancer that is difficult to define on an MRI.I have multiple tumors in one of my limbs.I have had radiation therapy on or near where my cancer started.I will start radiation therapy within 3 months after finishing chemotherapy.My treatment may include chemotherapy, as decided by my healthcare team.I agree to use effective birth control if I can have children.
- Group 1: extremity soft tissue sarcoma (STS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies for study participants in this research trial?
"Confirmed. Clinicaltrials.gov reveals that this experiment is still open for applications, with the first posting on February 26th 2020 and last update on May 16th 2022. The research requires 60 participants who will be recruited from 7 centres across America."
Is there any danger associated with Intensity-modulated radiation therapy (IMRT)?
"Our experts deem the safety of Intensity-modulated radiation therapy (IMRT) a credible 2. This is because while some data has been collected in relation to its safety, there are yet no studies that demonstrate efficacy."
What is the aggregate patient count for this clinical investigation?
"Affirmative. Clinicaltrials.gov attests that this research is seeking volunteers, with the initial post date of February 26th 2020 and most recent amendment on May 16th 2022. In total, 60 patients are needed to be enrolled at 7 medical facilities."
How many research centers are involved in this experiment?
"At the present, 7 centres are enrolling participants. These sites are dispersed across Uniondale, Harrison and Middletown as well as other areas. Should you take part in this investigation it is recommended to select a facility that is closest to your current location to reduce transport needs."
Share this study with friends
Copy Link
Messenger